<DOC>
	<DOCNO>NCT00583193</DOCNO>
	<brief_summary>The purpose study determine whether Duloxetine ( Cymbalta® ) effective treatment reduce symptom Posttraumatic Stress Disorder ( PTSD ) .</brief_summary>
	<brief_title>Open-Label Duloxetine Monotherapy Treatment Posttraumatic Stress Disorder</brief_title>
	<detailed_description>Duloxetine establish efficacy treatment major depression , generalize anxiety disorder diabetic peripheral neuropathic pain . Chronic PTSD often treat antidepressant , fact two FDA-approved treatment PTSD . Yet many chronic PTSD patient , especially male combat veteran , limited response antidepressant treatment ( Baker et al , 1995 ; Cañive et al , 1998 ; Hertzsberg et al 2000 ) new pharmacotherapies investigate .</detailed_description>
	<mesh_term>Stress Disorders , Traumatic</mesh_term>
	<mesh_term>Stress Disorders , Post-Traumatic</mesh_term>
	<mesh_term>Duloxetine Hydrochloride</mesh_term>
	<criteria>Male female patient age 18 old ethnic background meeting DSMIV criterion PTSD Score least 60 CAPSSX baseline Competent give inform consent If female , patient use medically approve contraceptive , otherwise childbearing potential Patients take medication herbal remedy psychiatric indication within one week prior baseline visit ( treatment phase ) ; two week prior case fluoxetine case MAOI Other medication , , must keep stable least one month prior baseline visit Known hypersensitivity duloxetine inactive ingredient Females pregnant breastfeed Use antipsychotic , antidepressant , benzodiazepine ( except shortterm use study specify Concomitant Medications section ) within one week prior baseline visit throughout study period Use fluoxetine MAOI within two week Concomitant use narrow therapeutic index medication medication likely clinically significant drug interaction duloxetine Medical condition may prevent safe administration duloxetine include end stage renal disease , clinically significant renal impairment ( CrCl &lt; 30 mL/min ) , hepatic insufficiency , cardiac disease , pulmonary disease Patients uncontrolled narrowangle glaucoma Alcohol drug abuse dependence within three month study entry define DSMIV criterion Alcohol use may exceed 12 drink per week 5 drink per drinking episode course study . A current past history bipolar disorder , schizophrenia , schizoaffective disorder psychotic disorder Suicidal homicidal ideation clinically significant dangerous behavior Currently seek compensation increase compensation effect trauma Initiation change psychotherapy within 3 month study entry</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2007</verification_date>
	<keyword>Post Traumatic Stress Disorder</keyword>
	<keyword>Duloxetine</keyword>
	<keyword>Antidepressants</keyword>
</DOC>